1. Gastrointestinal blood loss in haemodialysis patients during use of a lowmolecular-weight heparinoid anticoagulant;Frei, U.; Wilks, M.F.; Boehmer, S.;Nephrol Dial Transplant,1988
2. Iron induced increase in red cell size in haemodialysis patients;Gokal, R.; Weatherall, D.J.; Bunch, C.;Q J Med,1979
3. Bone marrow iron and plasma ferritin in dialysed patients given intravenous iron dextran;Fleming, L.W.; Saleem, A.K.N.; Goodall, H.B.; Stewart, W.K.;Clin Lab Haematol,1984
4. Iron metabolism in haemodialysis patients;Gokal, R.; Millard, P.R.; Weatherall, D.J.; Callender, S.T.E.; Ledingham, J.G.G.; Oliver, D.O.;Q J Med,1979
5. Failure of serum ferritin to predict bone-marrow iron content after intravenous iron-dextran therapy;Ali, M.; Rigolosi, R.; Fayemi, A.O.; Braun, E.V.; Frascino, J.; Singer, R.;Lancet,1982